Observational studyScientific reports2026
Serum transthyretin combined with first trimester uterine artery doppler ultrasound for preeclampsia prediction in singleton pregnancies: a prospective observational study.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This study aimed to evaluate the predictive value of serum transthyretin levels in conjunction with uterine artery Doppler ultrasound during the first trimester for predicting preeclampsia. We conducted a prospective observational study at King Chulalongkorn Memorial Hospital, Department of Obstetrics and Gynecology, Chulalongkorn University, Bangkok, Thailand. The study involved singleton pregnant women undergoing a first-trimester screening at a gestational age of 11–13+ 6 weeks. We measured maternal serum transthyretin levels and performed transabdominal uterine artery Doppler studies (mean pulsatility index, diastolic notching). Pregnancy outcomes were recorded, and the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the tests were calculated. The primary outcome was the sensitivity of serum transthyretin levels in conjunction with uterine artery Doppler ultrasound for predicting preeclampsia. The secondary outcomes were the specificity, PPV, and NPV of the tests. A total of 372 patients were analyzed, with preeclampsia occurring in 30 cases. Serum transthyretin levels were significantly lower in women with preeclampsia compared to those without (2.8 ng/ml vs. 7 ng/ml, p < 0.001). The mean pulsatility index of the uterine artery and the presence of diastolic notching did not significantly differ between the groups. Using a cut-off value of less than 0.5 multiples of the median for gestational age, the sensitivity, specificity, PPV, and NPV for predicting preeclampsia were 76.7%, 75.1%, 21.3%, and 97.4%, respectively. Furthermore, when combining abnormal transthyretin levels with abnormal uterine artery pulsatility index, the sensitivity was 76.7%, specificity 71.9%, PPV 19.3%, and NPV 97.2%. The combination of serum transthyretin and first-trimester uterine artery Doppler ultrasound was effective for predicting preeclampsia. Serum transthyretin may serve as a promising biomarker for early prediction of preeclampsia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.